Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | LVTX |
---|---|---|
10:06 ET | 100 | 1.9 |
10:10 ET | 100 | 1.99 |
10:30 ET | 2020 | 1.91 |
10:32 ET | 624 | 1.985 |
10:48 ET | 200 | 1.96 |
10:57 ET | 100 | 1.905 |
11:15 ET | 100 | 1.95 |
11:24 ET | 233 | 1.96 |
11:38 ET | 109 | 1.9415 |
11:40 ET | 450 | 1.9471 |
11:54 ET | 449 | 1.94 |
11:56 ET | 5652 | 1.9 |
11:58 ET | 200 | 1.89 |
12:03 ET | 400 | 1.8801 |
12:09 ET | 2200 | 1.89 |
12:30 ET | 1408 | 1.89 |
12:38 ET | 2510 | 1.9 |
12:41 ET | 10079 | 1.85 |
12:43 ET | 8098 | 1.8401 |
12:52 ET | 581 | 1.81 |
12:59 ET | 2600 | 1.87 |
01:01 ET | 997 | 1.86 |
01:14 ET | 100 | 1.9 |
01:35 ET | 1000 | 1.9 |
02:15 ET | 500 | 1.86 |
02:18 ET | 100 | 1.865 |
02:56 ET | 500 | 1.8501 |
03:00 ET | 100 | 1.8625 |
03:05 ET | 100 | 1.85 |
03:09 ET | 100 | 1.86 |
03:14 ET | 1334 | 1.85 |
03:16 ET | 200 | 1.86 |
03:21 ET | 400 | 1.86 |
03:25 ET | 100 | 1.85 |
03:34 ET | 740 | 1.86 |
03:38 ET | 100 | 1.85 |
03:39 ET | 100 | 1.86 |
03:43 ET | 100 | 1.865 |
03:48 ET | 100 | 1.865 |
03:52 ET | 200 | 1.88 |
03:57 ET | 500 | 1.8673 |
03:59 ET | 100 | 1.86 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
LAVA Therapeutics NV | 48.9M | -1.7x | --- |
Kezar Life Sciences Inc | 46.8M | -0.5x | --- |
DURECT Corp | 46.9M | -1.7x | --- |
BioLine RX Ltd | 51.6M | -0.8x | --- |
Kronos Bio Inc | 64.9M | -0.5x | --- |
Atara Biotherapeutics Inc | 40.4M | -0.2x | --- |
LAVA Therapeutics NV, formerly known as Lava Therapeutics BV, is a provider of biotechnology research and development services based in the Netherlands. The Company focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $48.9M |
---|---|
Revenue (TTM) | $12.5M |
Shares Outstanding | 26.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.07 |
Book Value | $1.95 |
P/E Ratio | -1.7x |
Price/Sales (TTM) | 3.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -252.58% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.